Resources

Liver Disease Information

In Your Area

Donate
Volunteer


Contact Us

American Liver Foundation
39 Broadway, Suite 2700
New York, New York 10006

212-668-1000 Tel
212-483-8179 Fax


Contact Us

American Liver Foundation
39 Broadway, Suite 2700
New York, New York 10006

212-668-1000 Tel
212-483-8179 Fax

Home > Divisions > Viral Hepatitis Treatment Choices

Viral Hepatitis Treatment Choices


The American Liver Foundation’s Treatment Choices Initiative (TCI) is an education program targeted to individuals who have or are at high risk of hepatitis C infection.

The program educates participants about the liver, liver disease, specifically hepatitis C, treatment options and other disease management strategies. The program also provides perspectives from hepatitis C positive individuals and additional support.

It is the American Liver Foundation’s hope that after participating in TCI, participants will have a greater awareness and understanding of the liver’s importance and will take action to improve their liver health and to prevent the spread of liver disease.


About the Program

Who?
The American Liver Foundation (ALF) facilitates, advocates and promotes education, support and research for the prevention, treatment and cure of liver disease.

What?
ALF’s Treatment Choices Initiative (TCI) is an education program targeted to individuals who have or are at high risk of hepatitis C infection. The program educates participants about the liver, liver disease, specifically hepatitis C, treatment options and other disease management strategies. The program also provides perspectives from hepatitis C positive individuals and additional support.

Where?
TCI programs are conducted at community-based organizations that serve individuals with or at high risk of hepatitis C infection. These include hospitals and clinics, veterans’ organizations, drug treatment facilities, homeless shelters, and drop in centers.

When?
TCI programs are scheduled in collaboration with community-based agencies and are available all year.

The 60-minute program educates participants about the liver, its functions, and strategies to maximize liver health. A healthcare professional provides an overview of viral hepatitis and details hepatitis C risks, transmission methods, prevention, impact, disease treatment and symptom management. A patient speaker offers his or her personal experience with hepatitis C. Program speakers and participants finish the program with a discussion of information and local resources.

Why?
It is the American Liver Foundation’s hope that after participating in TCI, participants will have a greater awareness and understanding of the liver’s importance and will take action to improve their liver health and to prevent the spread of liver disease.


About Hepatitis C

Hepatitis C is a disease of the liver that is caused by the hepatitis C virus, or HCV. Chronic hepatitis C is a serious condition that damages the liver and can lead to potentially fatal liver diseases such as cirrhosis, liver failure and liver cancer.

Learn more…


American Liver Foundation continues to receive positive feedback from individuals who have participated in the TCI program.

“Informative information that can save or add years to a persons well-being, gives hope to those infected with Hep C that programs and treatment are available.”
- TCI participant, Pennsylvania


“The staff found the presentation informative and relevant to their everyday work. There were so many questions and great interest that we hope to schedule another program in the next couple of months.”

- Community-based organization, Connecticut



Page updated: August 23rd, 2012